CVS Healthvs.McKesson
CVS vs MCK · both in Distribution & pharmacy infrastructure, part of the Medicine, pharma & life science value chain: Wholesalers, distribution and pharmacy chains that get medicines to patients.
CVS Health is about 1.4× larger than McKesson by market cap; McKesson trades at the lower P/E (19.8 vs 45.3); year to date, CVS Health leads (+31.2% vs −1.7%).
Side by side
| CVS | MCK | |
|---|---|---|
| Market cap | $133B | $94.4B |
| Price | $104.15 | $805.96 |
| Today | +1.3% | +1.7% |
| Return YTD | +31.2% | −1.7% |
| Return 1Y | +58.7% | +12.8% |
| P/E | 45.3 | 19.8 |
| P/S | 0.3 | 0.2 |
| P/B | 1.7 | 16.0 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
CVS HealthCVS
American healthcare group with a pharmacy chain, health insurance (Aetna) and a pharmacy benefit manager (Caremark).
Full CVS profile →McKessonMCK
American pharmaceutical wholesaler — one of the largest distributors of medicines to pharmacies, hospitals and clinics in the US.
Full MCK profile →More comparisons in Distribution & pharmacy infrastructure
See where CVS and MCK sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →